Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Meda Pharmaceuticals

Sky Way House, Parsonage Road, Takeley, Bishop's Stortford, CM22 6PU
Telephone: 0845 460 0000
Fax: 0845 460 0002
Medical Information Direct Line: +44 (0)1748 828 810
Medical Information e-mail: meda@professionalinformation.co.uk
Medical Information Fax: +44 (0)1748 828 801
Out of Hours contact: +44 (0)1748 828 810

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 06/08/2009
SPC DALMANE CAPSULES 15MG

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/08/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   01-Jun-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Change to Section 7. MAH, and Section 10. Date of Revision of Text
Updated on 02/08/2005 and displayed until 06/08/2009
Reasons for adding or updating:
  • Change to section 1 - trade name
Updated on 21/03/2005 and displayed until 02/08/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 18/03/2005 and displayed until 21/03/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 20/07/2004 and displayed until 18/03/2005
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Updated on 20/07/2004 and displayed until 20/07/2004
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Updated on 25/09/2002 and displayed until 20/07/2004
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 24/09/2002 and displayed until 25/09/2002
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
  flurazepam monohydrochloride